Scientist from Cambridge University have done Breast cancer treatment breakthrough. They have discovered the gene responsible for the most aggressive form of breast cancer, that is triple-negative breast cancer.

The discovery, which is called revolutionary, brings hope of new treatments. Triple-negative breast cancer tends to be more aggressive than other types of breast cancer. The quarter of patients having this form of cancer lives less than 5 years.

Researchers from Cambridge University and Wellcome Trust’s Sanger Institute discovered that the 80% patients having triple-negative breast cancer has an  excessive activity of the gene BCL11A. This research gives an opportunity to process a therapy for the gene inactivity, as well as to diagnose healthy women. In this case the will be able to pass prophylactic mastectomy.

In Great Britain nearly 10 000 people suffer from triple-negative breast cancer annually. Traditional breast cancer drugs, like herceptin, are useless against this disease.

The 936% of people suffering from other forms of breast tumors can live more than 5 years while in case of triple-negative breast cancer the number is only 77%.